Generic versions of popular weight loss and diabetes drugs, including GLP-1 medications, may become available soon. This could lead to significantly lower prices, potentially as low as $15 or $50 per month, increasing access to these medications for millions of people. The availability of generic versions is being considered in several countries, including the US and Canada, although the impact on safety and accessibility is still being debated.